Risedronic acid

USDailyMed:Risedronic AU:B3 M05BA07(WHO) AU:S4(Prescription only)UK:POM(Prescription only)US:℞-onlyIn general: ℞ (Prescription only) (1-hydroxy-1-phosphono-2-pyridin-3-yl-ethyl)phosphonic acid 105462-24-6Y 5245 3176 DB00884N 5055N KM2Z91756Z D00942D03234 ChEMB‍​‍‍‍​‍‍‍‍‍‍‍‍​‍L923N RIS (PDBe,RCSB PDB) DTXSID2023563 Interactive image OC(Cc1cccnc1)(P(=O)(O)O)P(=O)(O)O InChI=1S/C7H11NO7P2/c9-7(16(10,11)12,17(13,14)15)4-6-2-1-3-8-5-6/h1-3,5,9H,4H2,(H2,10,11,12)(H2,13,14,15)NKey:IIDJRNMFWXDHID-UHFFFAOYSA-NN Risedronic acid, often used as its sodium saltrisedronate sodium, is abisphosphonate.It slows down the cells which break down bone.It's used to treat or preventosteoporosis, and treatPaget's disease of bone.It is takenby mouth. It was patented in 1984 and approved for medical use in 1998.